Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 When and how to use maraviroc in HIV-infected patients.

Literature DB >> 19834318

When and how to use maraviroc in HIV-infected patients.

Vincent Soriano, Carlo-Federico Perno, Rolf Kaiser, Vincent Calvez, Jose M Gatell, Giovanni di Perri, Deenan Pillay, Juergen Rockstroh, Anna María Geretti.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19834318 DOI： 10.1097/QAD.0b013e328332d32d

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

1. Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India.

Authors: Ujjwal Neogi; Sreenivasa B Prarthana; George D'Souza; Ayesha Decosta; Vijesh S Kuttiatt; Udaykumar Ranga; Anita Shet
Journal: AIDS Res Ther Date: 2010-07-21 Impact factor: 2.250

2. In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells.

Authors: R Rossi; M Lichtner; A De Rosa; I Sauzullo; F Mengoni; A P Massetti; C M Mastroianni; V Vullo
Journal: Clin Exp Immunol Date: 2011-11 Impact factor: 4.330

3. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.

Authors: Muhammad Shoaib Arif; James Hunter; Ana Rachel Léda; Jean Paulo Lopes Zukurov; Sadia Samer; Michelle Camargo; Juliana Galinskas; Esper Georges Kallás; Shirley Vasconcelos Komninakis; Luiz Mario Janini; Maria Cecilia Sucupira; Ricardo Sobhie Diaz
Journal: J Virol Date: 2017-09-12 Impact factor: 5.103

Review 4. Clinical utility of maraviroc.

Authors: Jorge Parra; Joaquín Portilla; Federico Pulido; Rainel Sánchez-de la Rosa; Carlos Alonso-Villaverde; Juan Berenguer; José L Blanco; Pere Domingo; Fernando Dronda; Carlos Galera; Félix Gutiérrez; José M Kindelán; Hernando Knobel; Manuel Leal; Jose López-Aldeguer; Ana Mariño; Celia Miralles; José Moltó; Enrique Ortega; José A Oteo
Journal: Clin Drug Investig Date: 2011 Impact factor: 2.859

5. Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.

Authors: Mattia C F Prosperi; Laura Bracciale; Massimiliano Fabbiani; Simona Di Giambenedetto; Francesca Razzolini; Genny Meini; Manuela Colafigli; Angela Marzocchetti; Roberto Cauda; Maurizio Zazzi; Andrea De Luca
Journal: Retrovirology Date: 2010-06-30 Impact factor: 4.602

When and how to use maraviroc in HIV-infected patients.

1. Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India.

2. In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells.

3. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.

Review 4. Clinical utility of maraviroc.

5. Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.

Review 6. HIV-1 antiretroviral resistance: scientific principles and clinical applications.

7. The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach.

8. Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.

Review 9. Clinical use of CCR5 inhibitors in HIV and beyond.

10. Insights into the structure, correlated motions, and electrostatic properties of two HIV-1 gp120 V3 loops.